Hookipa Pharma Inc (HOOK)

Name: Hookipa Pharma Inc (HOOK) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Hookipa Pharma Inc (HOOK)

Stock Card

$1.15

$0.00 (0.00%)

As on 17-Jul-2026 09:30EDT

Market cap

$14 Mln

Revenue (TTM)

$15 Mln

P/E Ratio

P/B Ratio

0.5

Div. Yield

0 %

Hookipa Pharma Inc (HOOK) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 1.15 High: 1.15

52 Week Range

Low: 0.81 High: 1.20

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-1.1 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

0.5
Debt to Equity

0
Book Value

$2.6
EPS

$-1.1
Face value

--
Shares outstanding

9,976,985

7 Years Aggregate

CFO

$-251.52 Mln

EBITDA

$-353.25 Mln

Net Profit

$-319.30 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Hookipa Pharma Inc (HOOK)	28.8	0.0	0.0	0.9	-49.3	-57.1	--
BSE Sensex^*	-8.8	0.6	1.8	-4.4	6.0	6.6	10.8
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 17-Jul-2026 | *As on 28-Aug-2026 | #As on 26-Oct-2023

Company	2025	2024	2023	2022	2021	2020
Hookipa Pharma Inc (HOOK)	-55.6	-74.9	0.0	-65.2	-79.0	-9.3
S&P Small-Cap 600	4.0	7.0	13.9	-17.4	25.3	9.6
BSE Sensex	9.1	8.1	18.7	4.4	22.0	15.8

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Hookipa Pharma Inc (HOOK)	1.2	14.2	9.7	-13.8	-377.7	-33	--	0.5
Amneal Pharmaceuticals Inc Class A (AMRX)	17.5	6,109.1	3,117.6	157.4	14.7	--	37.3	190.1
Axsome Therapeutics (AXSM)	199.0	10,424.8	776.6	-191.6	-17.6	-223.4	--	129.6
BridgeBio Pharma (BBIO)	76.6	14,974.8	691.8	-696.2	-89.1	--	--	123.7
Corcept Therapeutics (CORT)	113.9	12,310.3	830.8	54.9	3.2	8.1	264.8	17.9
Elanco Animal Health (ELAN)	24.1	11,971.8	5,020.0	-199.0	1.6	-3	--	1.8
Grifols S.A. - ADR	7.7	5,233.7	7,430.4	452.5	17.6	7	10	0.8
Ligand Pharmaceuticals (LGND)	280.5	5,591.7	290.5	197.2	82.5	19.9	28.9	5.9
Liquidia Technologies Inc (LQDA)	67.7	6,058.9	450.9	138.6	39.1	115.6	50.1	32.1
Twist Bioscience Corp (TWST)	141.4	8,865.6	431.8	-136.7	-30.8	-30.3	--	21.5

Shareholding Pattern

View Details

About Hookipa Pharma Inc (HOOK)

HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunetherapeutics targeting infectious diseases based on its proprietary arenavirus platform. The company's immuno-oncology pipeline includes HB-700, a novel next-generation... multi-KRAS mutant-targeting investigational immunotherapy for the treatment of KRAS mutated cancers, including lung, colorectal, and pancreatic cancers; Eseba-vec, an investigational immunotherapeutic agent in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) head and neck cancers with enrollment completed in a Phase 1/2 clinical trial; and HB-300, which targets self-antigens for the treatment of prostate cancer. It is also developing HB-400 for the treatment of Hepatitis B that is in Phase I of clinical trial; and HB-500 for the treatment of Human Immunodeficiency Virus (HIV) that is in Phase I of clinical trial. The company has a collaboration and license agreement with Gilead Sciences, Inc. to collaborate on preclinical research programs to evaluate potential vaccine products for the treatment, cure, diagnosis, or prevention of the hepatitis B virus (HBV) and the HIV. HOOKIPA Pharma Inc. was incorporated in 2011 and is headquartered in New York, New York. Read more

CEO & Director

Mr. Joern Aldag
CEO & Director

Dr. Malte Peters M.D.
Headquarters

New York, NY
Website

https://www.hookipapharma.com

FAQs for Hookipa Pharma Inc (HOOK)

What is the current share price of Hookipa Pharma Inc (HOOK) Today?

The share price of Hookipa Pharma Inc (HOOK) is $1.15 (NASDAQ) as of 17-Jul-2026 09:30 EDT. Hookipa Pharma Inc (HOOK) has given a return of -49.3% in the last 3 years.

What is the current PB & PE ratio of Hookipa Pharma Inc (HOOK)?

Since, TTM earnings of Hookipa Pharma Inc (HOOK) is negative, P/E ratio is not available.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2025	-0.82	0.35
2024	-0.58	0.49
2023	-0.11	0.10
2022	-0.09	0.06
2021	-0.10	0.08

What is the 52 Week High and Low of Hookipa Pharma Inc (HOOK)?

The 52-week high and low of Hookipa Pharma Inc (HOOK) are Rs 1.20 and Rs 0.81 as of 30-Aug-2026.

What is the market cap of Hookipa Pharma Inc (HOOK)?

Hookipa Pharma Inc (HOOK) has a market capitalisation of $ 14 Mln as on 17-Jul-2026. As per SEBI classification, it is a Small Cap company.

Should I invest in Hookipa Pharma Inc (HOOK)?

Before investing in Hookipa Pharma Inc (HOOK), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.